Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan

Molnupiravir is a cost-effective treatment option for the treatment of older adult outpatients (age ≥ 65 years) with symptomatic COVID-19 in Japan, relative to best supportive care.

Authors

Institutions

Publication Details

Journal
PharmacoEconomics - Open
Published
2025-04-23
DOI
https://doi.org/10.1007/s41669-025-00578-y
Citations
3
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
4.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan

Atsushi Tajima, Hardik Goswami, Amy Puenpatom, Taizo Matsuki
3 citations
PharmacoEconomics - Open
Long-Term Effects of COVID-19
4.17
article

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan

Atsushi Tajima, Hardik Goswami, Amy Puenpatom, Taizo Matsuki
article en
3 citations

Abstract

Molnupiravir is a cost-effective treatment option for the treatment of older adult outpatients (age ≥ 65 years) with symptomatic COVID-19 in Japan, relative to best supportive care.

PharmacoEconomics - OpenVol. 9(4)
Gwynedd Mercy University (US), MSD K.K. (Japan) (JP)
Merck
Openalex Percentile: Top 7%
Long-Term Effects of COVID-19
4.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan — Atsushi Tajima, Hardik Goswami, et al. · PharmacoEconomics - Open (2025) | TGRS Research Map | TGRS